XSPRAY — XSpray Pharma AB (publ) Balance Sheet
0.000.00%
Last trade - 00:00
- SEK1.23bn
- SEK1.10bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 210 | 326 | 272 | 120 | 166 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5.44 | 2.67 | 2.5 | 2.58 | 4.17 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 216 | 331 | 282 | 132 | 218 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 43 | 42.7 | 44.6 | 64.6 | 108 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 401 | 605 | 623 | 585 | 765 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 22.5 | 19.8 | 30 | 28.9 | 39.9 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 27 | 22.7 | 31.2 | 29.4 | 71.8 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 374 | 583 | 592 | 556 | 693 |
Total Liabilities & Shareholders' Equity | 401 | 605 | 623 | 585 | 765 |
Total Common Shares Outstanding |